BBIO ▼ -1.0% - BridgeBio Pharma, Inc. $BBIO - BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026 03-NOV-2026 07:30 AM ET